Clinical Scenario:
An 8-year-old boy is admitted with a 4-day history of high-grade fever and vomiting. During admission, he becomes increasingly drowsy and develops two episodes of generalized tonic-clonic seizures. On examination, his Glasgow Coma Scale is 8/15. Fundoscopy is normal. Blood glucose is 92 mg/dL, serum sodium is 138 mmol/L, and cerebrospinal fluid examination is normal. Peripheral blood smear demonstrates Plasmodium falciparum.
What is the most appropriate initial treatment?
A. Intravenous artesunate
B. Intravenous quinine
C. Oral artemether-lumefantrine
D. Intravenous ceftriaxone
E. Exchange transfusion
Correct answer & Explanation:
Correct Answer: A. Intravenous artesunate
Explanation
This child has cerebral malaria, a life-threatening manifestation of severe malaria, most commonly caused by Plasmodium falciparum.
Cerebral malaria is characterized by impaired consciousness or coma in a patient with malaria, after other causes of altered consciousness have been excluded. Recurrent seizures are also common in children with severe malaria.
Important features of severe malaria include:
Impaired consciousness or coma
Repeated or prolonged seizures
Severe anemia
Hypoglycemia
Metabolic acidosis
Acute kidney injury
Respiratory distress
Shock
Hemoglobinuria
Why Option A is correct: Intravenous artesunate
Intravenous artesunate is the treatment of choice for severe malaria.
Artesunate rapidly reduces the circulating parasite burden and is preferred over quinine because it produces faster parasite clearance and has better survival outcomes in severe malaria.
Treatment should be started as soon as severe malaria is suspected or confirmed; treatment should not be delayed while waiting for additional investigations when clinical suspicion is high.
Once the child has received adequate parenteral therapy and can tolerate oral medication, treatment should be completed with an appropriate full oral antimalarial regimen, according to the local malaria treatment guideline.
Why the other options are incorrect
B. Intravenous quinine — Incorrect
Quinine is an effective antimalarial but is no longer preferred when intravenous artesunate is available. Quinine has a less favorable safety profile and is associated with adverse effects such as hypoglycemia, cinchonism, and cardiac arrhythmias.
C. Oral artemether-lumefantrine — Incorrect
Oral artemether-lumefantrine is used to complete treatment after initial parenteral therapy when the patient has improved sufficiently to tolerate oral medication. It should not be used as the initial treatment for a child with severe malaria who requires intravenous therapy.
D. Intravenous ceftriaxone — Incorrect
Ceftriaxone is appropriate for suspected bacterial meningitis or sepsis when these diagnoses cannot initially be excluded. However, it does not treat malaria and should not replace antimalarial therapy in confirmed severe malaria.
E. Exchange transfusion — Incorrect
Exchange transfusion has been proposed for very high parasite burdens, but routine exchange transfusion is not recommended as standard treatment for severe malaria because consistent clinical benefit has not been demonstrated.
Learning Point
Impaired consciousness/coma + malaria parasitemia ± recurrent seizures → think cerebral malaria.
Severe malaria requires urgent parenteral antimalarial treatment, with intravenous artesunate as the preferred first-line therapy. Supportive management is also essential, including careful management of seizures, hypoglycemia, anemia, fluid balance, acidosis, and other complications.
Exam Pearl
Severe falciparum malaria = IV artesunate first, then complete a full oral antimalarial course once the child can tolerate oral therapy.
Want to practice more MCQs? Solve another our post graduate level CNS MCQ.
